Stefan T Engelter1,2, Christopher Traenka3, Philippe Lyrer3. 1. Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland. stefan.engelter@fps-basel.ch. 2. Neurorehabilitation Unit, University of Basel and University Center for Medicine of Aging and Rehabilitation, Felix Platter Hospital, Burgfelderstrassse 101, 4002, Basel, Switzerland. stefan.engelter@fps-basel.ch. 3. Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland.
Abstract
PURPOSE OF REVIEW: We aimed to summarize recent findings in cervical (CeAD) and intracranial artery dissection (IAD) research. RECENT FINDINGS: Considered a disease of the young- and middle-aged, an analysis on the largest CeAD-population to date (n = 2391) revealed that about 1 of 14 CeAD-patients was aged ≥60 years. Distinct genetic variants were associated with CeAD. However, in clinical practice, genetic investigations are not helpful due to the small effect size. Despite the paucity of data from randomized-controlled trials in CeAD-stroke patients, both intravenous thrombolysis and endovascular treatment should be considered as acute treatment in such patients. Future research is needed to clarify which patients benefit most from each treatment modality. Whether to use antiplatelets or anticoagulants in stroke prevention in CeAD-patients is still a matter of debate. One randomized-controlled feasibility trial has been published, and another trial designed to show non-inferiority of aspirin to vitamin-K-antagonists is underway and will be terminated in late 2018. Non-vitamin-K-oral anticoagulants should not be used in CeAD outside a properly designed trial, as experience with these drugs in CeAD-patients is limited. With many IAD patients developing intracranial hemorrhage, antithrombotic therapy should be used with caution. Knowledge about CeAD and IAD has advanced substantially. Nevertheless, further research is mandatory, in particular regarding pathophysiology, acute treatment, and stroke-preventive therapy, as well as long-term outcome and prognosis.
PURPOSE OF REVIEW: We aimed to summarize recent findings in cervical (CeAD) and intracranial artery dissection (IAD) research. RECENT FINDINGS: Considered a disease of the young- and middle-aged, an analysis on the largest CeAD-population to date (n = 2391) revealed that about 1 of 14 CeAD-patients was aged ≥60 years. Distinct genetic variants were associated with CeAD. However, in clinical practice, genetic investigations are not helpful due to the small effect size. Despite the paucity of data from randomized-controlled trials in CeAD-strokepatients, both intravenous thrombolysis and endovascular treatment should be considered as acute treatment in such patients. Future research is needed to clarify which patients benefit most from each treatment modality. Whether to use antiplatelets or anticoagulants in stroke prevention in CeAD-patients is still a matter of debate. One randomized-controlled feasibility trial has been published, and another trial designed to show non-inferiority of aspirin to vitamin-K-antagonists is underway and will be terminated in late 2018. Non-vitamin-K-oral anticoagulants should not be used in CeAD outside a properly designed trial, as experience with these drugs in CeAD-patients is limited. With many IADpatients developing intracranial hemorrhage, antithrombotic therapy should be used with caution. Knowledge about CeAD and IAD has advanced substantially. Nevertheless, further research is mandatory, in particular regarding pathophysiology, acute treatment, and stroke-preventive therapy, as well as long-term outcome and prognosis.
Authors: A Zangerle; S Kiechl; M Spiegel; M Furtner; M Knoflach; P Werner; A Mair; G Wille; C Schmidauer; K Gautsch; T Gotwald; S Felber; W Poewe; J Willeit Journal: Neurology Date: 2007-01-02 Impact factor: 9.910
Authors: R W Baumgartner; M Arnold; I Baumgartner; M Mosso; F Gönner; A Studer; G Schroth; B Schuknecht; M Sturzenegger Journal: Neurology Date: 2001-09-11 Impact factor: 9.910
Authors: Tiina M Metso; Stéphanie Debette; Caspar Grond-Ginsbach; Stefan T Engelter; Didier Leys; Tobias Brandt; Alessandro Pezzini; Anna Bersano; Manja Kloss; Vincent Thijs; Philippe A Lyrer; Turgut Tatlisumak; Antti J Metso Journal: J Neurol Date: 2012-04-18 Impact factor: 4.849
Authors: L Kellert; M Kloss; A Pezzini; S Debette; D Leys; V Caso; V N Thijs; A Bersano; E Touzé; T Tatlisumak; C Traenka; P A Lyrer; S T Engelter; T M Metso; C Grond-Ginsbach Journal: Eur J Neurol Date: 2016-04-27 Impact factor: 6.089
Authors: William J Powers; Colin P Derdeyn; José Biller; Christopher S Coffey; Brian L Hoh; Edward C Jauch; Karen C Johnston; S Claiborne Johnston; Alexander A Khalessi; Chelsea S Kidwell; James F Meschia; Bruce Ovbiagele; Dileep R Yavagal Journal: Stroke Date: 2015-06-29 Impact factor: 10.170
Authors: Hakan Sarikaya; Bruno R da Costa; Ralf W Baumgartner; Kathleen Duclos; Emmanuel Touzé; Jean M de Bray; Antti Metso; Tiina Metso; Marcel Arnold; Antonio Arauz; Marcel Zwahlen; Peter Jüni Journal: PLoS One Date: 2013-09-05 Impact factor: 3.240
Authors: Christopher Traenka; Henrik Gensicke; Sabine Schaedelin; Andreas Luft; Marcel Arnold; Patrik Michel; Georg Kägi; Timo Kahles; Christian H Nolte; Lars Kellert; Sverre Rosenbaum; Roman Sztaizel; Alex Brehm; Christoph Stippich; Marios Psychogios; Philippe Lyrer; Stefan T Engelter Journal: Eur Stroke J Date: 2020-06-29
Authors: Christopher Traenka; Caspar Grond-Ginsbach; Barbara Goeggel Simonetti; Tiina M Metso; Stéphanie Debette; Alessandro Pezzini; Manja Kloss; Jennifer J Majersik; Andrew M Southerland; Didier Leys; Ralf Baumgartner; Valeria Caso; Yannick Béjot; Gian Marco De Marchis; Urs Fischer; Alexandros Polymeris; Hakan Sarikaya; Vincent Thijs; Bradford B Worrall; Anna Bersano; Tobias Brandt; Henrik Gensicke; Leo H Bonati; Emmanuel Touzeé; Juan J Martin; Hugues Chabriat; Turgut Tatlisumak; Marcel Arnold; Stefan T Engelter; Philippe Lyrer Journal: Neurology Date: 2019-11-22 Impact factor: 9.910
Authors: Philipp Erhart; Daniel Körfer; Susanne Dihlmann; Jia-Lu Qiao; Ingrid Hausser; Peter Ringleb; Jörg Männer; Nicola Dikow; Christian P Schaaf; Caspar Grond-Ginsbach; Dittmar Böckler Journal: J Clin Med Date: 2022-06-07 Impact factor: 4.964